| 1 |
25085632 | Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial. | 2014 Aug 1 |
2 |
| 2 |
21880693 | Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase. | 2012 Jan |
2 |
| 3 |
22399609 | CSF-1R up-regulation is associated with response to pharmacotherapy targeting tyrosine kinase activity in AML cell lines. | 2012 Mar |
2 |
| 4 |
21469976 | Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma. | 2011 May |
2 |
| 5 |
21577109 | Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. | 2011 Jul |
1 |
| 6 |
20877672 | Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast Cancer. | 2009 |
1 |
| 7 |
18347007 | Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. | 2008 Apr 10 |
1 |
| 8 |
18537751 | Developments in targeted therapy of advanced gastrointestinal stromal tumors. | 2008 Jun |
2 |
| 9 |
17367763 | Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. | 2007 May 4 |
2 |
| 10 |
16648572 | Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors. | 2006 Apr |
1 |